We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE (Cipla Australia Pty Ltd)
Product name
PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
134 (255 working days)
Active ingredients
pirfenidone
Registration type
New generic medicine
Indication
PIRFENIDONE CIPLA/ PIRFENEX/ CIP PIRFENIDONE is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).